Viewing Study NCT01135992


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-03-13 @ 9:47 PM
Study NCT ID: NCT01135992
Status: COMPLETED
Last Update Posted: 2016-01-22
First Post: 2010-05-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: